ChiCTR-IOR-15006129
结束
/
/
/
2015-03-20
/
/
people with cardiovascular risk factors
評估太極及步行運動對減少心血管風險因素的效果
評估太極及步行運動對減少心血管風險因素的效果
評估太極及步行運動對減少心血管風險因素的效果
随机平行对照
其它
RCT
Single-blind
Health and Medical Research Fund
/
246
/
2015-07-01
1990-01-01
/
Inclusion criteria: Subjects meet at least three but not more than four of the following CVD risk factors that are defined according to the American Heart Association:(3) 1. Males older than 45 years; 2. Females older than 55 years or postmenopausal; 3. Smoker; 4. Systolic blood pressure (SBP) >140 or diastolic blood pressure (DBP) >90 or taking blood pressure medication; 5. Fasting cholesterol level > 6.2 mmol/l 6. Have diabetes or taking medicine to control blood sugar; 7. Physically inactive (get <30 minutes of physical activity for at least 3 days a week); 8. BMI >25 kg/m2or waist circumference > 90 cm (men) or >80 cm (women).；
请登录查看1. Have developed cardiovascular disease; 2. Suffered from severe sensory or cognitive impairment; 3. Cannot walk independently; 4. Have musculoskeletal disorders or other disabling diseases that may limit the practice of tai chi; 5. Have previous training and practicing tai chi within a year prior to the commencement of the study.；
请登录查看Health and Medical Research Fund
/
Health and Medical Research Fund的其他临床试验
- Can whole-body vibration treatment optimize cognitive function in older adults who have sarcopenia and are at risk of dementia: A randomized controlled trial.
- The effects of motivational interviewing on promoting human papillomavirus vaccination intention, initiation and completion among South Asian mother/daughter dyads: a pilot randomised controlled trial
- Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations
- 香港新型冠狀病毒 (COVID-19) 隱形感染調查
- 醫療專業人員對出院後資訊匯總(PDIS)的看法:應用理論領域框架(TDF)來確定實施PDIS的障礙和促進因素
- Health Determinants for Late Onset Dementia and Its Associated Mortality in Hong Kong Chinese Older Adults
- 運動訓練對中度睡眠困擾的長者之影響:順序性混合方法研究
- 多種形式超聲心動圖預測射血分數正常的慢性穩定心力衰竭事件
- 網上心理健康計劃
- 評估太極及步行運動對減少心血管風險因素的效果
the Nthersole School of Nursing, CUHK的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04